Open AccessS0876 Assessment of Vedolizumab Disease-Drug-Drug Interaction in Patients With Inflammatory Bowel Diseases
Author(s) -
Wan Sun,
Richard A. Lirio,
Jennifer M. Schneider,
Jiri Aubrecht,
Harisha Kadali,
Mike Baratta,
Pooja Manchanda Gulati,
Ajit Suri,
Tsang Long Lin,
Raghavan Vasudevan,
Maria Rosario
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000705552.86216.e2
Subject(s) - medicine , vedolizumab , inflammatory bowel disease , ulcerative colitis , proinflammatory cytokine , cyp3a4 , cytokine , pharmacology , drug , therapeutic drug monitoring , cyp3a , biomarker , immunology , gastroenterology , cytochrome p450 , disease , inflammation , biochemistry , chemistry , metabolism